BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32934832)

  • 1. Effects of HIV and non-communicable disease comorbidity on healthcare costs and health experiences in people living with HIV in Zimbabwe.
    Gonah L; Moodley I; Hlongwana K
    South Afr J HIV Med; 2020; 21(1):1102. PubMed ID: 32934832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe.
    Gonah L; Moodley I; Hlongwana K
    Afr J Prim Health Care Fam Med; 2020 Aug; 12(1):e1-e6. PubMed ID: 32787407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capacity of antiretroviral therapy sites for managing NCDs in people living with HIV in Zimbabwe.
    Gonah L; Moodley I; Hlongwana K
    South Afr J HIV Med; 2020; 21(1):1113. PubMed ID: 32934835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe.
    Magodoro IM; Esterhuizen TM; Chivese T
    BMC Res Notes; 2016 Aug; 9():379. PubMed ID: 27484005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus and associated factors among HIV-positive patients at primary health care facilities in Harare, Zimbabwe: a descriptive cross-sectional study.
    Chireshe R; Manyangadze T; Naidoo K
    BMC Prim Care; 2024 Jan; 25(1):28. PubMed ID: 38221613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and determinants of non-communicable diseases including depression among HIV patients on antiretroviral therapy in Dar es Salaam, Tanzania.
    Mutagonda RF; Siril H; Kaaya S; Amborose T; Haruna T; Mhalu A; Urassa D; Mtisi E; Moshiro C; Tarimo E; Mahiti GR; Minja A; Somba M; August F; Mugusi F
    Trop Med Int Health; 2022 Aug; 27(8):742-751. PubMed ID: 35687423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, healthcare costs and management of non-communicable diseases in people living with human immunodeficiency virus: A scoping review.
    Gonah L; Moodley I; Hlongwana K
    Afr J Prim Health Care Fam Med; 2020 Oct; 12(1):e1-e8. PubMed ID: 33181877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intersecting Epidemics: The Predictors of Continued Utilization of HIV Care and Treatment Services During the COVID-19 Outbreak Among People Living with HIV in ZIMBABWE.
    Tapera T; Odimegwu C; Makoni T; Mukuwapasi W; Chitiyo V; Kadziyanike G; Willis N; Mutsinze A; Mawodzeke M; Chimberengwa P; Phiri M
    AIDS Behav; 2023 Oct; ():. PubMed ID: 37861922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated chronic care models for people with comorbid of HIV and non-communicable diseases in Sub-Saharan Africa: A scoping review.
    Chireshe R; Manyangadze T; Naidoo K
    PLoS One; 2024; 19(3):e0299904. PubMed ID: 38489252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hypertension and diabetes and associated risk factors among people living with human immunodeficiency virus in Southern Ethiopia.
    Badacho AS; Mahomed OH
    Front Cardiovasc Med; 2023; 10():1173440. PubMed ID: 37680566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does engagement in HIV care affect screening, diagnosis, and control of noncommunicable diseases in sub-Saharan Africa? A systematic review and meta-analysis.
    Kileel EM; Zheng A; Bor J; Fox MP; Crowther NJ; George JA; Khoza S; Rosen S; Venter WD; Raal F; Hibberd P; Brennan AT
    medRxiv; 2023 Jun; ():. PubMed ID: 36778439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life and associated factors in adults living with HIV in Rwanda.
    Biraguma J; Mutimura E; Frantz JM
    SAHARA J; 2018 Dec; 15(1):110-120. PubMed ID: 30200815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between a detectable HIV viral load and non-communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, South Africa.
    George S; McGrath N; Oni T
    BMC Infect Dis; 2019 Apr; 19(1):348. PubMed ID: 31029087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe.
    Burkhart Colorado AS; Lazzaro A; Neff CP; Nusbacher N; Boyd K; Fiorillo S; Martin C; Siebert JC; Campbell TB; Borok M; Palmer BE; Lozupone C
    Microbiome; 2024 Feb; 12(1):18. PubMed ID: 38310301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar es Salaam regions.
    Kagaruki GB; Mayige MT; Ngadaya ES; Kimaro GD; Kalinga AK; Kilale AM; Kahwa AM; Materu GS; Mfinanga SG
    BMC Public Health; 2014 Sep; 14():904. PubMed ID: 25183300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of non-communicable diseases (NCDs) in HIV patients on ART in a developing country: Case of Zimbabwe's Chitungwiza Central Hospital-A retrospective cohort study (2010-2019).
    Cheza A; Tlou B; Zhou DT
    PLoS One; 2021; 16(5):e0252180. PubMed ID: 34043718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini.
    Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P
    Elife; 2020 Aug; 9():. PubMed ID: 32831169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Engagement in HIV Care Affect Screening, Diagnosis, and Control of Noncommunicable Diseases in Sub-Saharan Africa? A Systematic Review and Meta-analysis.
    Kileel EM; Zheng A; Bor J; Fox MP; Crowther NJ; George JA; Khoza S; Rosen S; Venter WDF; Raal F; Hibberd P; Brennan AT
    AIDS Behav; 2024 Feb; 28(2):591-608. PubMed ID: 38300475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Factors Associated with Hypertension Among HIV Positive Patients on Antiretroviral Therapy: A Hospital-Based Cross-Sectional Study in Rwanda.
    Uwanyirigira D; Biracyaza E; Uzabakiriho I; Omolo J; Hakizayezu F; Nzayirambaho M
    Vasc Health Risk Manag; 2023; 19():857-870. PubMed ID: 38162226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial.
    Fatti G; Ngorima-Mabhena N; Chirowa F; Chirwa B; Takarinda K; Tafuma TA; Mahachi N; Chikodzore R; Nyadundu S; Ajayi CA; Mutasa-Apollo T; Mugurungi O; Mothibi E; Hoffman RM; Grimwood A
    Trials; 2018 Jan; 19(1):79. PubMed ID: 29378662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.